The Clinical Significance of Fetal Intra-Abdominal Umbilical Vein Varix A Comparative Study: A Comparative Study.

IF 2.4 4区医学 Q2 ACOUSTICS

Journal of Ultrasound in Medicine Pub Date : 2025-09-18 DOI:10.1002/jum.70048

Keren Zloto, Ariella Wiener, Natalie Bibar, Raanan Meyer, Abeer Massarwa, Michal Fishel Bartal, Alina Weissmann-Brenner, Eran Kassif, Tal Weissbach

{"title":"The Clinical Significance of Fetal Intra-Abdominal Umbilical Vein Varix A Comparative Study: A Comparative Study.","authors":"Keren Zloto, Ariella Wiener, Natalie Bibar, Raanan Meyer, Abeer Massarwa, Michal Fishel Bartal, Alina Weissmann-Brenner, Eran Kassif, Tal Weissbach","doi":"10.1002/jum.70048","DOIUrl":null,"url":null,"abstract":"Objectives: To clarify the clinical significance and optimal management of fetal intra-abdominal umbilical vein varix (FIUVV).Methods: A retrospective study comparing composite asphyxia-related adverse outcomes including stillbirth, cesarean delivery due to non-reassuring fetal heart rate (CD NRFHR), Apgar <7, Cord pH <7, neonatal intensive care unit admission, mechanical ventilation, seizures, asphyxia, and hypoxic ischemic encephalopathy, as well as rates of small for gestational age (SGA) and congenital anomalies, between FIUVV singletons and the general population born at a single center. A subgroup analysis included FIUVV singletons and controls delivering ≥39 weeks.Results: Compared to controls (99,715), FIUVV subjects (142) had more congenital anomalies (15.5% versus 0.84%, P < .01) and SGA (9.9% versus 5.4%, P = .02). There were no stillbirths among FIUVV. There were similar rates of CD NRFHR and asphyxia-related composite adverse outcomes between the study and control groups (4.2% versus 4.4%, P = .9; 7.7% versus 8.7%, P = .7) including the subgroup delivering ≥39 weeks (12.5% versus 4.6%, P = .06; 12.5% versus 5.7%, P = .09).Conclusions: FIUVV does not appear to increase asphyxia-related adverse outcomes. Targeted anomaly scan and growth assessment are recommended. There is no evidence to support labor induction before 39 weeks.","PeriodicalId":17563,"journal":{"name":"Journal of Ultrasound in Medicine","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ultrasound in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jum.70048","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ACOUSTICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives: To clarify the clinical significance and optimal management of fetal intra-abdominal umbilical vein varix (FIUVV).

Methods: A retrospective study comparing composite asphyxia-related adverse outcomes including stillbirth, cesarean delivery due to non-reassuring fetal heart rate (CD NRFHR), Apgar <7, Cord pH <7, neonatal intensive care unit admission, mechanical ventilation, seizures, asphyxia, and hypoxic ischemic encephalopathy, as well as rates of small for gestational age (SGA) and congenital anomalies, between FIUVV singletons and the general population born at a single center. A subgroup analysis included FIUVV singletons and controls delivering ≥39 weeks.

Results: Compared to controls (99,715), FIUVV subjects (142) had more congenital anomalies (15.5% versus 0.84%, P < .01) and SGA (9.9% versus 5.4%, P = .02). There were no stillbirths among FIUVV. There were similar rates of CD NRFHR and asphyxia-related composite adverse outcomes between the study and control groups (4.2% versus 4.4%, P = .9; 7.7% versus 8.7%, P = .7) including the subgroup delivering ≥39 weeks (12.5% versus 4.6%, P = .06; 12.5% versus 5.7%, P = .09).

Conclusions: FIUVV does not appear to increase asphyxia-related adverse outcomes. Targeted anomaly scan and growth assessment are recommended. There is no evidence to support labor induction before 39 weeks.

查看原文本刊更多论文

胎儿腹内脐静脉曲张的临床意义：一项比较研究。

目的：探讨胎儿腹内脐静脉曲张（FIUVV）的临床意义及处理方法。方法：一项回顾性研究比较了窒息相关的复合不良结局，包括死产、因胎儿心率不稳定（CD NRFHR）导致的剖宫产、Apgar结果：与对照组（99,715）相比，FIUVV组（142）有更多的先天性异常（15.5%比0.84%，P）结论：FIUVV似乎没有增加窒息相关的不良结局。建议进行有针对性的异常扫描和生长评估。没有证据支持在39周之前引产。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Ultrasound in Medicine 医学-核医学

CiteScore

5.10

自引率

4.30%

发文量

205

审稿时长

1.5 months

期刊介绍： The Journal of Ultrasound in Medicine (JUM) is dedicated to the rapid, accurate publication of original articles dealing with all aspects of medical ultrasound, particularly its direct application to patient care but also relevant basic science, advances in instrumentation, and biological effects. The journal is an official publication of the American Institute of Ultrasound in Medicine and publishes articles in a variety of categories, including Original Research papers, Review Articles, Pictorial Essays, Technical Innovations, Case Series, Letters to the Editor, and more, from an international bevy of countries in a continual effort to showcase and promote advances in the ultrasound community. Represented through these efforts are a wide variety of disciplines of ultrasound, including, but not limited to: -Basic Science- Breast Ultrasound- Contrast-Enhanced Ultrasound- Dermatology- Echocardiography- Elastography- Emergency Medicine- Fetal Echocardiography- Gastrointestinal Ultrasound- General and Abdominal Ultrasound- Genitourinary Ultrasound- Gynecologic Ultrasound- Head and Neck Ultrasound- High Frequency Clinical and Preclinical Imaging- Interventional-Intraoperative Ultrasound- Musculoskeletal Ultrasound- Neurosonology- Obstetric Ultrasound- Ophthalmologic Ultrasound- Pediatric Ultrasound- Point-of-Care Ultrasound- Public Policy- Superficial Structures- Therapeutic Ultrasound- Ultrasound Education- Ultrasound in Global Health- Urologic Ultrasound- Vascular Ultrasound